Novo Nordisk AS (NVO)
105.60
+2.97
(+2.89%)
USD |
NYSE |
Nov 22, 14:05
Novo Nordisk Total Assets (Quarterly): 59.53B for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 59.53B |
| June 30, 2024 | 53.03B |
| March 31, 2024 | 43.24B |
| December 31, 2023 | 46.69B |
| September 30, 2023 | 42.50B |
| June 30, 2023 | 40.97B |
| March 31, 2023 | 36.60B |
| December 31, 2022 | 34.72B |
| September 30, 2022 | 32.10B |
| June 30, 2022 | 30.74B |
| March 31, 2022 | 29.58B |
| December 31, 2021 | 29.61B |
| September 30, 2021 | 27.16B |
| June 30, 2021 | 25.30B |
| March 31, 2021 | 22.29B |
| December 31, 2020 | 23.95B |
| September 30, 2020 | 22.07B |
| June 30, 2020 | 20.53B |
| March 31, 2020 | 18.65B |
| December 31, 2019 | 18.83B |
| September 30, 2019 | 18.30B |
| June 30, 2019 | 17.96B |
| March 31, 2019 | 16.55B |
| December 31, 2018 | 16.97B |
| September 30, 2018 | 15.85B |
| Date | Value |
|---|---|
| June 30, 2018 | 16.02B |
| March 31, 2018 | 15.47B |
| December 31, 2017 | 16.49B |
| September 30, 2017 | 15.49B |
| June 30, 2017 | 15.05B |
| March 31, 2017 | 13.53B |
| December 31, 2016 | 13.87B |
| September 30, 2016 | 13.14B |
| June 30, 2016 | 13.20B |
| March 31, 2016 | 12.52B |
| December 31, 2015 | 13.45B |
| September 30, 2015 | 12.85B |
| June 30, 2015 | 12.22B |
| March 31, 2015 | 11.23B |
| December 31, 2014 | 12.58B |
| September 30, 2014 | 12.15B |
| June 30, 2014 | 11.65B |
| March 31, 2014 | 11.64B |
| December 31, 2013 | 13.02B |
| September 30, 2013 | 12.33B |
| June 30, 2013 | 11.23B |
| March 31, 2013 | 10.73B |
| December 31, 2012 | 11.64B |
| September 30, 2012 | 11.54B |
| June 30, 2012 | 10.21B |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
18.65B
Minimum
Mar 2020
59.53B
Maximum
Sep 2024
32.90B
Average
30.17B
Median
Total Assets (Quarterly) Benchmarks
| Ascendis Pharma AS | 1.222B |
| Amgen Inc | 90.88B |
| AstraZeneca PLC | 104.92B |
| Grifols SA | 22.65B |
| Viking Therapeutics Inc | 937.89M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 41.48B |
| Shareholders Equity (Quarterly) | 18.05B |
| Debt to Equity Ratio | 0.4727 |
| Current Ratio | 0.9367 |
| Net Debt Paydown Yield | -0.18% |